MicroRNA in cancer therapy: breakthroughs and challenges in early clinical applications
Indexed incrossrefdoajpubmed
Abstract
MicroRNAs (miRNAs) have emerged as pivotal regulators in cancer biology, influencing tumorigenesis, progression, and resistance to therapy. Their ability to modulate multiple oncogenic and tumor-suppressive pathways positions them as promising therapeutic tools or targets. This review examines the dual role of miRNAs in solid and hematological malignancies, starting from their dysregulation in various cancer types. Therapeutic approaches, including miRNA replacement and inhibition strategies, are discussed alongside innovative delivery systems such as lipid nanoparticles and exosomes. Despite their transformative potential, challenges persist, including off-target effects, immune activation, and delivery…
Citation impact
147
total citations
- FWCI
- 107.34
- Percentile
- 100%
- References
- 101
Citations per year
Authors
3Topics & keywords
Topics
Keywords
- microRNA
- Microvesicles
- Cancer
- Clinical trial
- Transformative learning
- Medicine
- Carcinogenesis
- Cancer therapy
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.